20 Sep 2017 | 8:19 AM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
796.85
-2.90
(-0.36 %)
19 Sep 2017 | 03:46 PM
Change company
  • Open (Rs)
    812.00
  • Prev. close (Rs.)
    799.75
  • High (Rs.)
    818.00
  • Low (Rs.)
    793.30
  • 52W H (Rs.)
    1,080.00
  • 52W L (Rs.)
    495.00
  • Volume (Rs.)
    25974
  • MCap (Rs in Cr.)
    13,889.74
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
27.88
Operating Margin (%)
33.82
Gross Profit Margin (%)
31.13
Net Profit Margin (%)
24.05
Total Debt/Equity
0.13
Dividend payout Ratio (Net Profit)
29.13
Earning Retention Ratio
70.80

News

14 Aug 2017 - 16:25:00-Natco Pharma said that it has received the final approval of Abbreviated New Drug Application (ANDA)...
14 Aug 2017 - 16:25:00-Natco Pharma said that it has received the final approval of Abbreviated New Drug Application (ANDA)...
07 Aug 2017 - 17:13:00-Drug maker Natco Pharma has reported standalone net profit of Rs 97...
07 Aug 2017 - 17:13:00-Drug maker Natco Pharma has reported standalone net profit of Rs 97...

Announcements

30-Aug-2017
Natco Pharma - Fixes Book Closure for AGM
29-Aug-2017
Natco Pharma - AGM/Book Closure
29-Aug-2017
Natco Pharma - Fixes Book Closure For Annual General Meeting
17-Aug-2017
Natco Pharma - Change Of The Annual General Meeting Date
16-Aug-2017
Natco Pharma - Updates

Religare Research

20 Sep 2017 | 07:00 AM
Markets are at record high and cues from the global front are still mixed. In such scenario, it’s pr...
19 Sep 2017 | 10:00 AM
The Indian rupee fell to a four-week low against the dollar, as state-run lenders bought the greenba...
19 Sep 2017 | 09:17 AM
• Gold dipped as equities and dollar surged ahead of Fed meeting • Oil prices steadied, held near re...
19 Sep 2017 | 07:00 AM
We suggest refraining from aggressive positions amid mixed signals and preferring hedged positions u...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 32.97 0.00
4,00,000 90.05 139.33 0.00
4,00,000 90.05 145.95 0.01
4,00,000 90.05 53.11 0.00
1,60,000 35.89 92.92 0.12

Shareholding Pattern

       
Promotors51.24%
Mutual Funds/UTI5.01%
FI/Banks2.28%
Insurance2.28%
FII19.41%
Government0.00%
Others3.38%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,775.00(-2.40)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,410.00(0.02)
3317
 Dr. Reddy`s Laboratories Ltd.
2,239.10(-0.25)
3294
 Alkem Laboratories Ltd.
1,779.20(-1.25)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.73.15-182.20-5.95
NIFTY(S&P CNX)393.20490.001,020.70
BSE SENSEX1,143.521,090.802,883.63
BSE 500715.36823.111,670.43

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
Natco House Road No.2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Natco Pharma Ltd. that will help you decide whether to buy, sell or hold Natco Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Natco Pharma Ltd.